Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

about

Portable devices and mobile instruments for infectious diseases point-of-care testing.

P2860

Q30235078-FF371F4C-CA92-48EA-ABD2-D9221FE1883C

P2860

Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

Item

http://www.wikidata.org/entity/Q38675080

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Sample-to-result molecular inf ...... ns, limitations and potential.

@en

type

Item

label

Sample-to-result molecular inf ...... ns, limitations and potential.

@en

prefLabel

Sample-to-result molecular inf ...... ns, limitations and potential.

@en

P1476

Sample-to-result molecular inf ...... ns, limitations and potential.

@en

P2093

Kenneth H Rand

http://www.w3.org/2001/XMLSchema#string

Naziheh Assarzadegan

http://www.w3.org/2001/XMLSchema#string

Stacy G Beal

http://www.w3.org/2001/XMLSchema#string

P2860

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

Foodborne illness acquired in the United States--major pathogens

Field evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in Tanzania

Rapid molecular detection of tuberculosis and rifampin resistance

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

Evaluation and verification of the nanosphere Verigene RV+ assay for detection of influenza A/B and H1/H3 subtyping.

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

Review of use of a new rapid real-time PCR, the Cepheid GeneXpert® (Xpert) CT/NG assay, for Chlamydia trachomatis and Neisseria gonorrhoeae: results for patients while in a clinical setting.

Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections

P304

323-341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737159.2016.1134325

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26689497

http://www.w3.org/2001/XMLSchema#string

P932

7103687

http://www.w3.org/2001/XMLSchema#string

Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

about

P2860

P2860

Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932